Trials / Conditions / Tumors Metastatic to Brain

Tumors Metastatic to Brain

16 registered clinical trials studyying Tumors Metastatic to Brain — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer NCT02312622	Joel Neal	Phase 2
Terminated	Quantitative MRI in Assessing Disease in Patients With Brain Tumors NCT02269111	Vanderbilt-Ingram Cancer Center	N/A
Completed	Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma NCT02107755	Ohio State University Comprehensive Cancer Center	Phase 2
Recruiting	Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study NCT01891318	Case Comprehensive Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases NCT01843413	Case Comprehensive Cancer Center	Phase 1
Withdrawn	Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole NCT02277561	Albert Einstein College of Medicine	N/A
Completed	Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma NCT01703507	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 1
Completed	Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases Fr NCT00992602	University of Washington	Phase 2
Completed	Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases NCT01276210	Vanderbilt-Ingram Cancer Center	Phase 1
Completed	Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases NCT01234740	City of Hope Medical Center	Phase 1
Terminated	Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung NCT00937482	National Cancer Institute (NCI)	Phase 1
Completed	Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer NCT01706432	University of Chicago	—
Completed	Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases NCT00098605	National Cancer Institute (NCI)	Phase 2
Completed	Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma NCT00072163	National Cancer Institute (NCI)	Phase 2
Completed	Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases NCT00033254	National Cancer Institute (NCI)	Phase 3
Withdrawn	Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positiv NCT02145910	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 1